1. Home
  2. QNRX vs OCTO Comparison

QNRX vs OCTO Comparison

Compare QNRX & OCTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QNRX
  • OCTO
  • Stock Information
  • Founded
  • QNRX 2018
  • OCTO 1966
  • Country
  • QNRX United States
  • OCTO United States
  • Employees
  • QNRX N/A
  • OCTO N/A
  • Industry
  • QNRX Medical/Dental Instruments
  • OCTO
  • Sector
  • QNRX Health Care
  • OCTO
  • Exchange
  • QNRX Nasdaq
  • OCTO Nasdaq
  • Market Cap
  • QNRX 4.3M
  • OCTO 4.2M
  • IPO Year
  • QNRX N/A
  • OCTO N/A
  • Fundamental
  • Price
  • QNRX $7.20
  • OCTO $1.51
  • Analyst Decision
  • QNRX
  • OCTO
  • Analyst Count
  • QNRX 0
  • OCTO 0
  • Target Price
  • QNRX N/A
  • OCTO N/A
  • AVG Volume (30 Days)
  • QNRX 4.5K
  • OCTO 3.0M
  • Earning Date
  • QNRX 08-07-2025
  • OCTO 08-19-2025
  • Dividend Yield
  • QNRX N/A
  • OCTO N/A
  • EPS Growth
  • QNRX N/A
  • OCTO N/A
  • EPS
  • QNRX N/A
  • OCTO N/A
  • Revenue
  • QNRX N/A
  • OCTO $43,871,615.00
  • Revenue This Year
  • QNRX N/A
  • OCTO N/A
  • Revenue Next Year
  • QNRX N/A
  • OCTO N/A
  • P/E Ratio
  • QNRX N/A
  • OCTO N/A
  • Revenue Growth
  • QNRX N/A
  • OCTO N/A
  • 52 Week Low
  • QNRX $5.01
  • OCTO $0.98
  • 52 Week High
  • QNRX $54.95
  • OCTO $4.86
  • Technical
  • Relative Strength Index (RSI)
  • QNRX 43.44
  • OCTO 51.06
  • Support Level
  • QNRX $7.05
  • OCTO $1.33
  • Resistance Level
  • QNRX $7.30
  • OCTO $1.63
  • Average True Range (ATR)
  • QNRX 0.33
  • OCTO 0.10
  • MACD
  • QNRX 0.05
  • OCTO -0.02
  • Stochastic Oscillator
  • QNRX 41.14
  • OCTO 58.14

About QNRX Quoin Pharmaceuticals Ltd.

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

About OCTO Eightco Holdings Inc.

Eightco Holdings Inc operates in Forever 8 Inventory Cash Flow Solution. The company is a dynamic technology-focused company committed to driving growth and innovation through strategic acquisitions and management. Forever 8 focuses on purchasing inventory for e-commerce retailers and is part of its Inventory Solution Business.

Share on Social Networks: